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The origins and early development of palliative care focussed on patients with cancer, apart from 
sporadic developments in a few non-malignant diseases such as MND and HIV. In the UK, this has 
been compounded by the setting of palliative care outside the National Health Service, principally 
funded by cancer-related charities who, at the time were instituted to relieve the suffering 
associated with cancer. When the modern hospice movement began, the course of malignant 
disease was seen as more predictable, with a defined palliative phase when anti-cancer treatments 
were no longer indicated. In the UK and many areas of the world where it was first adopted such as 
the Canada, USA, mainland Europe and Australia, this led to the traditional model of palliative care 
services, involved only in people with a prognosis of a few weeks or months.  As a result, services 
have focused primarily on cancer leading to service and symptom management inequalities for 
equally needy patients with non-malignant diseases.  
Meanwhile, advances in cancer therapy have changed the course of malignant diseases, in some 
cases, to mirror that of long term conditions. Many palliative care services have been able to adapt 
their service model to one of integrated care alongside the oncology team. Although an integrated 
approach to palliative care access appears to be more difficult to do in the USA and other countries 
where funding for such services remain linked to the traditional “either/or” model(1), recent 
evidence from the USA supports earlier access to palliative care services in metastatic non-small-cell 
lung cancer in terms of improved quality of life, and more surprisingly, survival(1).  
The move to palliative care services for people with cancer according to need rather than prognosis 
resonates with literature that highlights patients with non-malignant conditions having an 
equivalent, or in some studies greater, symptom and carer burden compared with those with 
cancer(2, 3). Although the needs of patients with diseases other than cancer may last longer, they 
have less access to supportive and palliative care(4). The call for specialist palliative care services to 
accept patients according to need rather than diagnosis is embedded in the 2008 End of Life Strategy 
in the UK(5). However, compliance with this aspect of policy remains inconsistent so that many local 
services fail to support patients with a wide range of diagnoses. The referral rate for patients with 
non-malignant diseases is improving in the UK, but remains comparatively low and does not yet 
match the need of patients and their carers.(6)  
Over 15 years ago, extrapolating from cancer data, it was estimated that, of those who die from non-
malignant disease in England and Wales each year, over 71,000 people may need specialist palliative 
care.(7) Recent reports from Germany and Australia indicate that non-cancer patients are still in the 
minority within specialised inpatient palliative care institutions(2, 3). It is only now, as palliative 
medicine is expanding into non-malignant diseases, that a picture is emerging and symptom based 
research in patients dying of non-malignant disease is beginning to reveal the true extent of patient 
and carer needs in this population. 
 
 
Challenges for specialist palliative care services 
 In North America and Europe, the population is growing older with a consequential increase in the 
prevalence of long term conditions. It is estimated that by 2031 people aged over 65 will make up 
22% of the UK population with a concomitant rise in the death rate, along side the prevalence 
chronic conditions (8). However, one of the biggest challenges to health and social care services is 
the increase in those with dementia, multiple co-morbidity and frailty. Inherent in these 
demographic changes is a reduction in the number of spouses and contemporaries able to do the 
informal caring. With the age of retirement rising, employment may claim the 60 to 70 year olds 
who currently provide many hours of unpaid support for those at the end of life. This landscape is 
very different from the traditional cancer-related palliative care services in hospices and specialist 
units.  
 
Changing funding structures and service performance assessments 
Hospice and palliative care services have been slow to embrace outcome measurements to 
demonstrate the benefits of their services(9).  Palliative care services need sustainable funding to 
provide the best possible care for the patient population that require their skills. In an ever harsher 
financial climate, funders need to be convinced, perhaps now more than at any other time in the 
history of the hospice movement, of the cost effectiveness, in terms of net-benefit, of palliative care 
services.  Such net benefit should be recognised as important and relevant to patients, caregivers, 
clinical staff, and the health system providing care with clear outcome measures for each domain 
(9).  
 
The future of hospice care 
As long ago as 1963, Hinton observed that distress in the dying was not necessarily greatest in those 
with cancer(10). Fifty years later, palliative care services are starting to respond to the needs of 
those with other conditions. However, radical changes are required in order for them to ensure their 
relevance to patients, carers, clinicians and commissioners. In a patient outcome driven health 
service, it is vital that they engage in competition for funding, ensuring appropriate competencies 
and establishing a role in the new world of multi-morbidity, dementia and frailty. Skills with 
symptom management, communication and care of the dying patient are deeply rooted, valuable 
and transferable; but evidence regarding the best way for palliative clinicians to disseminate these 
skills in the care of people with non-malignant disease is still of low quality. A UK Commission into 
the Future of Hospice Care led by Help the Hospices (a major UK charity) has been set up in response 
to this required change in direction and is expected to report in the autumn of 2013. 
If we accept the premise that provision of adequate palliative care, particularly at the end of life for 
patients with all diseases, is a matter of equity, then services will be required to change. The nature 
of the change required to achieve equity of provision is less clear. The imperative of palliative care 
service provision for those with non-malignant disease raises three very important questions for the 
future of specialist palliative care service provision in this much broader context: 
• What are the palliative care needs of changing populations?  
• What is the role of specialist palliative care services in addressing these needs for patients 
with all diagnoses?  
• What is the most cost-effective way to provide such services systematically throughout 
health services?  
In this issue, we see some welcome exploration of the challenge, but guess what? Further urgent 
research is vital. 
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